FDA changes status of convalescent plasma program
New Emergency Use Authorization could make COVID-19 therapy more readily available to coronavirus patients The Food and Drug Administration has changed the status of COVID-19
New Emergency Use Authorization could make COVID-19 therapy more readily available to coronavirus patients The Food and Drug Administration has changed the status of COVID-19
Convalescent plasma, first discovered in the 19th century, authorized for use in fight against coronavirus A doctor’s reaction to a potential epidemic almost 90 years
46-month research demonstrates safety of FDA guidance for low pulse rate population Blood donors with low pulse rates experience fewer negative reactions than the general
Dr. Jairo Melo, one of San Antonio’s biggest proponents of convalescent plasma treatments, has a simple message for anyone who has recovered from COVID-19. “I
Members of Americas Blood Centers, including the South Texas Blood & Tissue Center, aim to double the number of doses available in August